This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Company Filing History:
1 out of 834,350 Years Active: 2002
Title: Katherine Galvin: Innovator in Cardiovascular Research
Introduction
Katherine Galvin is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cardiovascular research through her innovative work and patented inventions. Her research focuses on understanding cardiovascular diseases and developing potential treatments.
Latest Patents
Katherine Galvin holds a patent for "Compositions and methods for the treatment and diagnosis of cardiovascular disease." This invention is centered around the generation and phenotypic characterization of transgenic knockout homozygous rchd534 mutant mice. These mice exhibit characteristic symptoms of cardiovascular disease, making them valuable models for analyzing the role of rchd534 protein in cardiovascular system development and homeostasis. The research also explores tissue-specific regulation of the TGF-β signaling pathways. These transgenic mice can be utilized for screening compounds that may be effective in treating or preventing cardiovascular disease.
Career Highlights
Throughout her career, Katherine has demonstrated a commitment to advancing medical research and innovation. Her work has the potential to impact the diagnosis and treatment of cardiovascular diseases significantly.
Collaborations
Katherine has collaborated with notable professionals in her field, including Dennis Huszar and Michael A Gimbrone, Jr. These collaborations have further enriched her research and contributed to the advancement of cardiovascular science.
Conclusion
Katherine Galvin is a dedicated inventor whose work in cardiovascular research is paving the way for new diagnostic and treatment methods. Her innovative approach and patented inventions are crucial in the ongoing fight against cardiovascular diseases.